Using evidence to change antimalarial drug policy in Kenya

Tropical Medicine and International Health

Volumn 5, Issue 11, 2000, Pages 755-764

  Shretta, R ^a   Omumbo, J ^b   Rapuoda, B ^c   Snow, R W ^a,d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b MINISTRY OF HEALTH   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

Author keywords

Chloroquine resistance; Drug policy; Kenya

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

DISEASE TREATMENT; DRUG PRESCRIBING; DRUG RESISTANCE; MALARIA;

ANTIBIOTIC RESISTANCE; ARTICLE; DECISION MAKING; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG SENSITIVITY; ENDEMIC DISEASE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; KENYA; MALARIA; ORGANIZATION; PLASMODIUM; PRACTICE GUIDELINE; TREATMENT FAILURE;

ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; KENYA; MALARIA;

KENYA;

EID: 0034536076     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2000.00643.x     Document Type: Article

References (48)

1. A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar® in the treatment of uncomplicated malaria in children
2. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa
3. Making malaria treatment policy in the face of drug resistance
4. Chloroquine in Africa: Critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa
5. Sensitivity of Plasmodium falciparum to chloroquine in coastal and western Kenya: Update
6. Failure of erythromycin to improve chloroquine treatment of Plasmodium falciparum malaria in Kenya
7. Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance
8. A malariometric survey in Turkana District; Kenya: Chemosensitivity in vivo of Plasmodium falciparum infections and identity of vector
9. Serum concentrations of chloroquine in a patient with late recrudescence of Kenyan Plasmodium falciparum malaria
10. Chloroquine vs pyrimethamine/sulphadoxine in the treatment of uncomplicated malaria in northern Kenya
11. Chloroquine-resistant Plasmodium falciparum malaria in Kenya
12. Cost-effectiveness of malaria control in sub-Saharan Africa
13. Predicting malaria seasons in Kenya using multitemporal metereological satellite sensor data
14. In vivo falciparum malaria response to chloroquine in Kisumu, Kenya
15. In vivo and in vitro response to chloroquine and amodiaquine in children in Nyanza province 1987
16. Malaria endemicity in central division, Kitui district, Kenya, October 1983
17. Parasitological, clinical and haematological response of children with Plasmodium falciparum malaria to 4-aminoquinoline and to pyrimethamine/sulphadoxine with quinine in Western Kenya
18. Drug sensitivity studies during a highland malaria epidemic in Kenya
19. Sensitivity of Plasmodium falciparum to chloroquine in Busia District, Kenya
20. Changing the Management of Malaria in Kenya: A Strategy Document to Introduce New Guidelines, Clinical Practice and Patient Awareness for the Treatment of Malaria
21. The role of drug delivery systems in health care: The case of self-medication
22. A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya
23. Response of falciparum malaria in vivo to a standard regimen of chloroquine in Kisumu District, Western Kenya
24. Sensitivity of falciparum malaria to chloroquine and amodiaquine in four districts in Western Kenya
25. Mapping malaria transmission intensity using geographical information systems (GIS): An example from Kenya
26. Surveillance of Plasmodium falciparum resistance to chloroquine in Kenya: Sensitivity test of Plasmodium falciparum to chloroquine in Nangina, Busia district
27. Chloroquine resistant malaria from East Africa
28. Application of a simplified in vivo test system for determining chloroquine resistance in Plasmodium falciparum
29. Status of antimalarial drugs sensitivity in Kenya
30. Malaria: Living with drug resistance
31. Models to predict the intensity of Plasmodium falciparum transmission: Applications to the burden of disease in Kenya
32. Sensitivity of Plasmodium falciparum isolates to chloroquine in Kisumu and Malindi, Kenya
33. The Kenyan Saradidi Community Malaria Project: Response of Plasmodium falciparum isolates in 1981 and 1982
34. Amodiaquine more effective than chloroquine against Plasmodium falciparum malaria on the Kenya coast
35. In vivo response of Plasmodium falciparum to chloroquine in pregnant and non-pregnant women in Siaya District, Kenya
36. Treatment of chloroquine-resistant malaria in African children: A cost-effectiveness analysis
37. Impact of chloroquine resistance on malaria mortality
38. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya
39. Chemotherapy of Malaria and Resistance to Antimalarials